Affiliation:
1. Blood and Tissues Bank of Aragón (BTBA) Zaragoza Aragón Spain
2. Hemotic Olite Navarra Spain
3. Department of Statistical Methods and Institute for Biocomputation and Physics of Complex Systems (BIFI) University of Zaragoza Zaragoza Aragón Spain
Abstract
AbstractBackground and ObjectivesThe variability in the number of donations together with a growing demand for platelet concentrates and plasma‐derived medicines make us seek solutions aimed at optimizing the processing of blood. Some mathematical models to improve efficiencies in blood banking have been published. The goal of this work is to validate and evaluate an algorithm's impact in the production of blood components in the Blood and Tissues Bank of Aragon (BTBA).Materials and MethodsA mathematical algorithm was designed, implemented and validated through simulations with real data. It was incorporated into the fractionation area, which uses the Reveos® fractionation system (Terumo BCT) to split blood into its components. After 9 months of daily routine validation, retrospective activity data from the Blood Bank and Transfusion Services before and during the use of the algorithm were compared.ResultsUsing the algorithm, the outdating rate of platelet concentrates (PC) decreased by 87.8% in the blood bank. The average shelf life remaining of PC supplied to Transfusion Services increased by almost 1 day. As a consequence, the outdating rate in the Aragon Transfusion Network decreased by 33%. In addition, extra 100 litres of plasma were obtained in 9 months.ConclusionsThe algorithm improves the blood establishment's workflow and facilitates the decision‐making process in whole blood processing. It resulted in a decrease in PC outdating rate, increase in PC shelf life and finally an increase in the volume of recovered plasma, leading to significant cost savings.
Reference30 articles.
1. The current state of the platelet supply in the
US
and proposed options to decrease the risk of critical shortages
2. Current challenges in platelet transfusion
3. KluszczynskiT RohrS ErnstR.White paper key economic and value considerations for plasma‐derived medicinal products (PDMPs) in Europe.2020. Available from:https://www.vintura.com/wp‐content/uploads/2020/03/White‐paper‐key‐economic‐and‐value‐considerations‐for‐plasma‐derived‐medicinal‐products‐PDMPs‐in‐Europe_Vintura‐and‐PPTA.pdf. Last accessed 25 May 2023.
4. Pathogen Reduction: A Precautionary Principle Paradigm
5. Terumo BCT.Mirasol. 2023. Available from:https://www.terumobct.com/mirasol. Last accessed 25 May 2023.